• Home
  • About
    • About EIPG
    • The Statute
    • Bureau and Executive
      • The Past Presidents Advisory Committee
    • Member States
    • EIPG Awards
      • EIPG Award Recipients
  • Information
    • Guides and Codes
    • Position Papers
  • Education
  • Media Library
    • Presentations
    • Photo Gallery
  • News
    • From the Bureau
    • News from EIPG
    • EU Focus
    • Regulatory Affairs
    • Business & Policies
    • Technology & Research
  • Members
    • Members Area
    • Webinars
  • Contact Us
Login Area

Members Area

 

Follow Us
Facebook
Twitter
LinkedIn
YouTube
Slideshare
EIPG Logo
  • Home
  • About
    • About EIPG
    • The Statute
    • Bureau and Executive
      • The Past Presidents Advisory Committee
    • Member States
    • EIPG Awards
      • EIPG Award Recipients
  • Information
    • Guides and Codes
    • Position Papers
  • Education
  • Media Library
    • Presentations
    • Photo Gallery
  • News
    • From the Bureau
    • News from EIPG
    • EU Focus
    • Regulatory Affairs
    • Business & Policies
    • Technology & Research
  • Members
    • Members Area
    • Webinars
  • Contact Us

EIPG Feedback on draft Questions and Answers on production of Water for Injections

The European Medicines Agency recently launched a public consultation on draft questions and answers on production of water for injections by non-distillation methods – reverse osmosis and biofilms and control strategies. EIPG has reviewed the document and, following feedback from its members, has submitted its comments to the EMA.

Read the EIPG Feedback on the draft questions and answers.

  • In memory of John Jolley
    • April 24, 2025
  • EMA guideline on investigational ATMPs
    • April 24, 2025
  • The proposal of a Critical Medicines Act
    • April 4, 2025
  • EIPG Webinar | The Cumulative Impact of Environment and Chemical Legislation and the future of the Healthcare Sector | Kirsty Reid
    • March 25, 2025
  • The Clean Industrial Deal and the Omnibus package on simplification
    • March 25, 2025
  • The FDA’s Advanced Manufacturing Technologies Designation Program
    • March 9, 2025
  • The EU’s Competitiveness Compass and the new EU Biotech Hub
    • February 21, 2025
  • The EU AI Act: compliance obligations and business opportunities in 2025
    • February 17, 2025
  • PIC/S’ new guidances on remote and hybrid inspections
    • February 5, 2025
  • ICH E6(R3): a new era for Good Clinical Practice in industrial pharmacy
    • January 31, 2025
EU Transparency Register
EIPG is registered in the EU
Transparency Register with public ID
number 979567925318-36

0
0
0
33
0
Disclaimer and Privacy Policy
  • Privacy Policy
  • Disclaimer
Contacts
  • General Inquiries
  • President
  • Executive Director
  • Vice-President Communications